Disparities in Breast Cancer Treatment and Outcomes: Biological, Social, and Health System Determinants and Opportunities for Research
Top Cited Papers
Open Access
- 12 August 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 18 (9), 986-993
- https://doi.org/10.1634/theoncologist.2013-0243
Abstract
Racial disparities in breast cancer mortality have been widely documented for several decades and persist despite advances in receipt of mammography across racial groups. This persistence leads to questions about the roles of biological, social, and health system determinants of poor outcomes. Cancer outcomes are a function not only of innate biological factors but also of modifiable characteristics of individual behavior and decision making as well as characteristics of patient-health system interaction and the health system itself. Attempts to explain persistent racial disparities have mostly been limited to discussion of differences in insurance coverage, socioeconomic status, tumor stage at diagnosis, comorbidity, and molecular subtype of the tumor. This article summarizes existing literature exploring reasons for racial disparities in breast cancer mortality, with an emphasis on treatment disparities and opportunities for future research. Because breast cancer care requires a high degree of multidisciplinary team collaboration, ensuring that guideline recommended treatment (such as endocrine therapy for hormone receptor positive patients) is received by all racial/ethnic groups is critical and requires coordination across multiple providers and health care settings. Recognition that variation in cancer care quality may be correlated with race (and socioeconomic and health system factors) may assist policy makers in identifying strategies to more equally distribute clinical expertise and health infrastructure across multiple user populations.Keywords
Funding Information
- Agency for Healthcare Research
- Quality Comparative Effectiveness Research Career Development Award (1-K-12 HS019468-01)
This publication has 99 references indexed in Scilit:
- Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancerBreast Cancer Research and Treatment, 2011
- Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancerBreast Cancer Research and Treatment, 2010
- Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancerAnnals of Oncology, 2009
- Mammography facilities are accessible, so why is utilization so low?Cancer Causes & Control, 2009
- The Effect of Hospital and Surgeon Volume on Racial Differences in Recurrence-Free Survival After Radical ProstatectomyMedical Care, 2008
- Evaluation of Trends in the Cost of Initial Cancer TreatmentJNCI Journal of the National Cancer Institute, 2008
- Epidemiology of basal-like breast cancerBreast Cancer Research and Treatment, 2007
- Early discontinuation of tamoxifenCancer, 2007
- Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyJAMA, 2006
- Adherence to tamoxifen over the five-year courseBreast Cancer Research and Treatment, 2006